GH - Guardant Health, Inc.

QQQ $ 474.86 $ 2.12 (0.45 %)

DIA $ 414.87 $ 2.97 (0.72 %)

SPY $ 561.82 $ 2.92 (0.52 %)

TLT $ 100.40 $ 0.27 (0.27 %)

GLD $ 238.66 $ 2.35 (0.99 %)

Previous Close

$ 26.79

Open

$ 25.89

Bid

$ 26.78 x 200

Ask

-- x --

Day's Range

$ 25.50 - $ 27.08

52 Week Range

$ 15.81 - $ 37.04

Volume

3,800,587

Average Volume

Market Cap

3.3B

Beta (5Y Monthly)

$ 1.19

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	11-06-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-02-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	03-19-2019	12-31-2018	10-K
24	11-19-2018	09-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guardant Health Partners With Agostino Gem...
09/10/2024 12:13:55

pdd-holdings-daqo-new-energy-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

PDD Holdings, Daqo New Energy And Other Bi...
08/26/2024 12:25:39

UBS Maintains Buy on Guardant Health, Rais...
08/21/2024 13:51:51

UBS analyst Dan Leonard maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $32 to $40.

Piper Sandler Maintains Overweight on Guar...
08/13/2024 15:21:05

Piper Sandler analyst David Westenberg maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target f...

cathie-woods-ark-invest-continues-loads-up-on-605m-worth-of-robinhood-shares-amid-bitcoin-rebound-dumps-zoom-stock

Cathie Wood's Ark Invest Continues Loads U...
08/09/2024 02:38:59

On Thursday, Cathie Wood-led Ark Invest made some significant trades, notably buying Robinhood Markets Inc (NASDAQ:HOOD) and se...

Citigroup Maintains Buy on Guardant Health...
08/08/2024 19:23:08

Citigroup analyst Patrick Donnelly maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $40 to ...

TD Cowen Maintains Buy on Guardant Health,...
08/08/2024 18:06:34

TD Cowen analyst Dan Brennan maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $41 to $42.

Key Takeaways From Guardant Health Analyst...
08/08/2024 18:00:49

Craig-Hallum Maintains Buy on Guardant Hea...
08/08/2024 16:06:01

Craig-Hallum analyst Alex Nowark maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $28 to $37.

JP Morgan Maintains Overweight on Guardant...
08/08/2024 15:46:30

JP Morgan analyst Julia Qin maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target from $45 to ...

Guardant Health Raises FY24 Revenue Exclud...
08/07/2024 20:23:43

Guardant Health continues to expect full year 2024 non-GAAP gross margin excluding screening to be in the range of 61% to 63% a...

Guardant Health Q2 2024 Adj. EPS $(0.48) B...
08/07/2024 20:06:28

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.74)...

Guardant Health Announces COSMOS Study Res...
08/07/2024 12:24:14

Highlights Clinical Utility Of ctDNA For Rapid Evaluation Without Prior Tissue Analysis; Guardant Reveal Test Demonstrates High...

Guardant Health Announces FDA Approval And...
08/01/2024 12:33:07

BTIG Maintains Buy on Guardant Health, Rai...
07/30/2024 16:40:00

BTIG analyst Mark Massaro maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $45 to $50.

fda-greenlights-guardant-healths-shield-blood-test-analyst-cautious-on-adoption

FDA Greenlights Guardant Health's Shield B...
07/29/2024 17:21:32

FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-appro...

Guardant Health's Shield Blood Test for Co...
07/29/2024 10:31:11

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration ...

Guardant Health Launches Enhanced Guardant...
07/23/2024 12:09:49

cathie-wood-led-ark-invest-sells-8m-in-tesla-shares-despite-bullish-autonomy-forecast

Cathie Wood-Led Ark Invest Sells $8M In Te...
07/19/2024 02:12:11

B of A Securities Maintains Buy on Guardan...
07/18/2024 12:42:17

B of A Securities analyst Michael Ryskin maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $...